<p>VT-PCV7: IPD caused by PCV7 serotypes; VT-PCV13: IPD caused by 6 additional serotypes in PCV13; NVT: non vaccine serotypes.</p
Streptococcus pneumoniae serotype 1 (ST1) was an important cause of invasive pneumococcal disease (I...
In the Netherlands, the national immunization program includes 7-valent pneumococcal conjugate vacci...
Objectives Burden of pneumococcal disease depends on the prevalence and invasive disease potential o...
<p>PCV7 serotypes include serotypes 4, 6B, 9V, 14, 18C, 19F and 23F. PHiD-CV10 shows the additional ...
Background. Changes in invasive pneumococcal disease (IPD) incidence were evaluated after 7 years of...
<p>IPD yearly incidence per 100,000 population pre-vaccination (0 years) and after 10 and 40 years p...
<p><b>Serotype distribution of IPD in children (<5 years) (A) and older adults (>65 years) (B).</b> ...
Rates of IPD expressed as cases per 100,000 population are on the y-axis, and calendar year of surve...
Streptococcus pneumoniae serotype 1 (ST1) was an important cause of invasive pneumococcal disease (I...
Streptococcus pneumoniae serotype 1 (ST1) was an important cause of invasive pneumococcal disease (I...
Streptococcus pneumoniae serotype 1 (ST1) was an important cause of invasive pneumococ-cal disease (...
AbstractSince 2010, Denmark has included the 13-valent pneumococcal conjugated vaccine (PCV-13) in t...
<p>The serotype distribution in the two periods analyzed 1999–2000 (pre-PCV7, n = 174 isolates) and ...
Adult invasive pneumococcal disease (IPD) occurs mainly in the elderly and patients with co-morbidit...
<p>Serotype distribution among 295 pneumococcal isolates causing adult IPD in more recent years (per...
Streptococcus pneumoniae serotype 1 (ST1) was an important cause of invasive pneumococcal disease (I...
In the Netherlands, the national immunization program includes 7-valent pneumococcal conjugate vacci...
Objectives Burden of pneumococcal disease depends on the prevalence and invasive disease potential o...
<p>PCV7 serotypes include serotypes 4, 6B, 9V, 14, 18C, 19F and 23F. PHiD-CV10 shows the additional ...
Background. Changes in invasive pneumococcal disease (IPD) incidence were evaluated after 7 years of...
<p>IPD yearly incidence per 100,000 population pre-vaccination (0 years) and after 10 and 40 years p...
<p><b>Serotype distribution of IPD in children (<5 years) (A) and older adults (>65 years) (B).</b> ...
Rates of IPD expressed as cases per 100,000 population are on the y-axis, and calendar year of surve...
Streptococcus pneumoniae serotype 1 (ST1) was an important cause of invasive pneumococcal disease (I...
Streptococcus pneumoniae serotype 1 (ST1) was an important cause of invasive pneumococcal disease (I...
Streptococcus pneumoniae serotype 1 (ST1) was an important cause of invasive pneumococ-cal disease (...
AbstractSince 2010, Denmark has included the 13-valent pneumococcal conjugated vaccine (PCV-13) in t...
<p>The serotype distribution in the two periods analyzed 1999–2000 (pre-PCV7, n = 174 isolates) and ...
Adult invasive pneumococcal disease (IPD) occurs mainly in the elderly and patients with co-morbidit...
<p>Serotype distribution among 295 pneumococcal isolates causing adult IPD in more recent years (per...
Streptococcus pneumoniae serotype 1 (ST1) was an important cause of invasive pneumococcal disease (I...
In the Netherlands, the national immunization program includes 7-valent pneumococcal conjugate vacci...
Objectives Burden of pneumococcal disease depends on the prevalence and invasive disease potential o...